MedTrace Logo

A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris

NCT02758041 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2017-09-07

No results posted yet for this study

Summary

This study is proposed to evaluate Sebacia Microparticle treatment in patients with facial inflammatory acne vulgaris.

Conditions

  • Facial Acne Vulgaris

Interventions

DEVICE

Sebacia Microparticles

Sponsors & Collaborators

  • Sebacia, Inc.

    lead INDUSTRY

Principal Investigators

  • Merete Haedersdal, MD, PhD · Department of Dermatology, Bispebjerg Hospital, Univ of Copenhagen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-01-31
Completion
2017-02-28

Countries

  • Denmark
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02758041 on ClinicalTrials.gov